A hallmark of CML is the Philadelphia chromosome (Ph), which results in a BCR-ABL1 fusion gene and constitutive tyrosine kinase activity. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.